Competitive chemiluminescent enzyme immunoassay for vitamin B12 analysis in human milk

Abstract

Recent discoveries of matrix interferences by haptocorrin (HC) in human milk and serum show that past analyses of vitamin B12 in samples with high HC content might have been inaccurate (Lildballe et al., 2009; Carmel & Agrawal, 2012). We evaluated two competitive enzyme-binding immunoassays for serum/plasma (IMMULITE and SimulTRAC-SNB) for B12 analysis in human milk. B12-recovery rates (United States Environmental Protection Agency, 2007) were determined to be 78.9±9.1% with IMMULITE and 225±108% (range 116–553%) using SimulTRAC-SNB, most likely due to the presence of excess HC. HC-interferences were not observed with the IMMULITE assay, rendering previously reported mandatory HC-removal (Lildballe et al., 2009) unnecessary. Linearity continued at low B12-concentrations (24–193pM; r2>0.985). Milk B12 concentrations from Bangladeshi women (72–959pM) were significantly lower than those from California (154–933pM; p<0.0001) showing IMMULITE’s robustness against the complex milk matrix and its ability to measure low milk B12 concentrations.